Somewhat Positive News Coverage Somewhat Unlikely to Affect IMS Health (IMS) Stock Price

Press coverage about IMS Health (NYSE:IMS) has trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. IMS Health earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned media coverage about the information technology services provider an impact score of 42.7482475657508 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Shares of IMS Health (NYSE:IMS) traded up $0.99 during trading on Wednesday, reaching $31.34. 4,031,300 shares of the company were exchanged, compared to its average volume of 1,266,943. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 2.53. IMS Health has a 12-month low of $22.36 and a 12-month high of $31.59. The stock has a market cap of $10,330.00 and a PE ratio of 74.62.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.chaffeybreeze.com/2018/01/03/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-ims-health-ims-stock-price.html.

About IMS Health

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Insider Buying and Selling by Quarter for IMS Health (NYSE:IMS)

Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply